Nox, reactive oxygen species and regulation of vascular cell fate

Antioxidants

Volumn 6, Issue 4, 2017, Pages

  Burtenshaw, Denise ^a   Hakimjavadi, Roya ^a   Redmond, Eileen M ^b   Cahill, Paul A ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Adventitial cells; Arteriosclerotic disease; Endothelial; Intimal medial thickening; Nox; ROS; Stem cells; Vascular smooth muscle

Indexed keywords

EID: 85034819555     PISSN: None     EISSN: 20763921     Source Type: Journal    
DOI: 10.3390/antiox6040090     Document Type: Review

References (143)

1. Lassègue, B.; San Martín, A.; Griendling, K.K. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 2012, 110, 1364–1390.
2. Kelley, E.E. A new paradigm for XOR-catalyzed reactive species generation in the endothelium. Pharmacol. Rep. 2015, 67, 669–674.
3. Dolinsky, V.W.; Cole, L.K.; Sparagna, G.C.; Hatch, G.M. Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins. Biochim. Biophys. Acta 2016, 1861, 1544–1554.
4. Montezano, A.C.; Touyz, R.M. Reactive oxygen species and endothelial function—Role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin. Pharmacol. Toxicol. 2012, 110, 87–94.
5. Förstermann, U.; Xia, N.; Li, H. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Circ. Res. 2017, 120, 713–735.
6. Ellulu, M.S.; Patimah, I.; Khaza’ai, H.; Rahmat, A.; Abed, Y.; Ali, F. Atherosclerotic cardiovascular disease: A review of initiators and protective factors. Inflammopharmacology 2016, 24, 1–10.
7. Loot, A.E.; Schreiber, J.G.; Fisslthaler, B.; Fleming, I. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J. Exp. Med. 2009, 206, 2889–2896.
8. Burgoyne, J.R.; Madhani, M.; Cuello, F.; Charles, R.L.; Brennan, J.P.; Schröder, E.; Browning, D.D.; Eaton, P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317, 1393–1397.
9. Bennett, M.R.; Sinha, S.; Owens, G.K. Vascular Smooth Muscle Cells in Atherosclerosis. Circ. Res. 2016, 118, 692–702.
10. Vanhoutte, P.M.; Shimokawa, H.; Feletou, M.; Tang, E.H.C. Endothelial dysfunction and vascular disease—A 30th anniversary update. Acta Physiol. 2017, 219, 22–96.
11. Shankman, L.S.; Swiatlowska, P.; Williams, J.; Alencar, G.F.; Bevard, M.H.; Greene, E.S.; Murgai, M.; Turner, S.D.; Connelly, J.J.; Owens, G.K. Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective. Nat. Med. 2016, 22, 657–665.
12. Tang, Z.; Wang, A.; Yuan, F.; Yan, Z.; Liu, B.; Chu, J.S.; Helms, J.A.; Li, S. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat. Commun. 2012, 3, 875.
13. Kramann, R.; Schneider, R.K.; DiRocco, D.P.; Machado, F.; Fleig, S.; Bondzie, P.A.; Henderson, J.M.; Ebert, B.L.; Humphreys, B.D. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015, 16, 51–66.
14. Cooley, B.C.; Nevado, J.; Mellad, J.; Yang, D.; St Hilaire, C.; Negro, A.; Fang, F.; Chen, G.; San, H.; Walts, A.D.; et al. TGF-ß signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci. Transl. Med. 2014, 6, 227ra34–227ra34.
15. Zhang, L.; Xu, Q. Stem/Progenitor cells in vascular regeneration. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 1114–1119.
16. Xie, C.; Ritchie, R.P.; Huang, H.; Zhang, J.; Chen, Y.E. Smooth muscle cell differentiation in vitro: Models and underlying molecular mechanisms. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1485–1494.
17. Kurpinski, K.; Lam, H.; Chu, J.; Wang, A.; Kim, A.; Tsay, E.; Agrawal, S.; Schaffer, D.V.; Li, S. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 2010, 28, 734–742.
18. Yuan, F.; Wang, D.; Xu, K.; Wang, J.; Zhang, Z.; Yang, L.; Yang, G.-Y.; Li, S. Contribution of Vascular Cells to Neointimal Formation. PLoS ONE 2017, 12, e0168914.
19. Wan, M.; Li, C.; Zhen, G.; Jiao, K.; He, W.; Jia, X.; Wang, W.; Shi, C.; Xing, Q.; Chen, Y.-F.; Jan De Beur, S.; Yu, B.; Cao, X. Injury-activated transforming growth factor ß controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells 2012, 30, 2498–2511.
20. Bobryshev, Y.V.; Orekhov, A.N.; Chistiakov, D.A. Vascular stem/progenitor cells: Current status of the problem. Cell Tissue Res. 2015, 362, 1–7.
21. Yao, E.-H.; Yu, Y.; Fukuda, N. Oxidative Stress on Progenitor and Stem Cells in Cardiovascular Diseases. Curr. Pharm. Biotechnol. 2006, 7, 101–108.
22. Nègre-Salvayre, A.; Augé, N.; Camaré, C.; Bacchetti, T.; Ferretti, G.; Salvayre, R. Dual signaling evoked by oxidized LDLs in vascular cells. Free Radic. Biol. Med. 2017, 106, 118–133.
23. Di, A.; Mehta, D.; Malik, A.B. ROS-activated calcium signaling mechanisms regulating endothelial barrier function. Cell Calcium 2016, 60, 163–171.
24. Rubio-Gayosso, I.; Platts, S.H.; Duling, B.R. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2006, 290, H2247–56.
25. Pervaiz, S.; Taneja, R.; Ghaffari, S. Oxidative Stress Regulation of Stem and Progenitor Cells. Antioxid. Redox Signal. 2009, 11, 2777–2789.
26. Daiber, A.; Di Lisa, F.; Oelze, M.; Kröller-Schön, S.; Steven, S.; Schulz, E.; Münzel, T. Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. Br. J. Pharmacol. 2017, 174, 1670–1689.
27. Zhang, J.; Wang, X.; Vikash, V.; Ye, Q.; Wu, D.; Liu, Y.; Dong, W. ROS and ROS-Mediated Cellular Signaling. Oxid. Med. Cell. Longev. 2016, 2016, 4350965.
28. Ganeva, M.G.; Getova, D.P.; Gadjeva, V.G. Adverse drug reactions and reactive oxygen species. Folia Med. (Plovdiv.) 2008, 50, 5–11.
29. Lambeth, J.D. Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy. Free Radic. Biol. Med. 2007, 43, 332–347.
30. Lambeth, J.D.; Kawahara, T.; Diebold, B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 2007, 43, 319–331.
31. Skonieczna, M.; Hejmo, T.; Poterala-Hejmo, A.; Cieslar-Pobuda, A.; Buldak, R.J. NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells. Oxid. Med. Cell. Longev. 2017, 2017, 9420539.
32. Siu, K.L.; Gao, L.; Cai, H. Differential Roles of Protein Complexes NOX1-NOXO1 and NOX2-p47phox in Mediating Endothelial Redox Responses to Oscillatory and Unidirectional Laminar Shear Stress. J. Biol. Chem. 2016, 291, 8653–8662.
33. Przybylska, D.; Janiszewska, D.; Gozdzik, A.; Bielak-Zmijewska, A.; Sunderland, P.; Sikora, E.; Mosieniak, G. NOX4 downregulation leads to senescence of human vascular smooth muscle cells. Oncotarget 2016, 7, 66429–66443.
34. Haurani, M.J.; Cifuentes, M.E.; Shepard, A.D.; Pagano, P.J. Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension 2008, 52, 143–149.
35. Lee, J.-E.; Cho, K.E.; Lee, K.E.; Kim, J.; Bae, Y.S. Nox4-mediated cell signaling regulates differentiation and survival of neural crest stem cells. Mol. Cells 2014, 37, 907–911.
36. Drummond, G.R.; Sobey, C.G. Endothelial NADPH oxidases: Which NOX to target in vascular disease? Trends Endocrinol. Metab. 2014, 25, 452–463.
37. Bedard, K.; Krause, K.-H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007, 87, 245–313.
38. Lambeth, J.D.; Neish, A.S. Nox enzymes and new thinking on reactive oxygen: A double-edged sword revisited. Annu. Rev. Pathol. 2014, 9, 119–145.
39. Takac, I.; Schröder, K.; Zhang, L.; Lardy, B.; Anilkumar, N.; Lambeth, J.D.; Shah, A.M.; Morel, F.; Brandes, R.P. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 2011, 286, 13304–13313.
40. Forte, M.; Nocella, C.; De Falco, E.; Palmerio, S.; Schirone, L.; Valenti, V.; Frati, G.; Carnevale, R.; Sciarretta, S. The Pathophysiological Role of NOX2 in Hypertension and Organ Damage. High Blood Press Cardiovasc. Prev. 2016, 23, 355–364.
41. Ueyama, T.; Nakakita, J.; Nakamura, T.; Kobayashi, T.; Kobayashi, T.; Son, J.; Sakuma, M.; Sakaguchi, H.; Leto, T.L.; Saito, N. Cooperation of p40(phox) with p47(phox) for Nox2-based NADPH oxidase activation during Fc? receptor (Fc?R)-mediated phagocytosis: Mechanism for acquisition of p40(phox) phosphatidylinositol 3-phosphate (PI(3)P) binding. J. Biol. Chem. 2011, 286, 40693–40705.
42. El-Benna, J.; Dang, P.M.-C.; Gougerot-Pocidalo, M.-A. Priming of the neutrophil NADPH oxidase activation: Role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin. Immunopathol. 2008, 30, 279–289.
43. Lyle, A.N.; Deshpande, N.N.; Taniyama, Y.; Seidel-Rogol, B.; Pounkova, L.; Du, P.; Papaharalambus, C.; Lassègue, B.; Griendling, K.K. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 2009, 105, 249–259.
44. Carrizzo, A.; Forte, M.; Lembo, M.; Formisano, L.; Puca, A.A.; Vecchione, C. Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases. Curr. Drug Targets 2014, 15, 1231–1246.
45. Miyano, K.; Sumimoto, H. Assessment of the role for Rho family GTPases in NADPH oxidase activation. Methods Mol. Biol. 2012, 827, 195–212.
46. Coughlin, S.R. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J. Thromb. Haemost. 2005, 3, 1800–1814.
47. Bäumer, A.T.; Ten Freyhaus, H.; Sauer, H.; Wartenberg, M.; Kappert, K.; Schnabel, P.; Konkol, C.; Hescheler, J.; Vantler, M.; Rosenkranz, S. Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47phox is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species. J. Biol. Chem. 2008, 283, 7864–7876.
48. Lien, G.-S.; Wu, M.-S.; Bien, M.-Y.; Chen, C.-H.; Lin, C.-H.; Chen, B.-C. Epidermal growth factor stimulates nuclear factor-?B activation and heme oxygenase-1 expression via c-Src, NADPH oxidase, PI3K, and Akt in human colon cancer cells. PLoS ONE 2014, 9, e104891.
49. Bondi, C.D.; Manickam, N.; Lee, D.Y.; Block, K.; Gorin, Y.; Abboud, H.E.; Barnes, J.L. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J. Am. Soc. Nephrol. 2010, 21, 93–102.
50. Weaver, J.R.; Holman, T.R.; Imai, Y.; Jadhav, A.; Kenyon, V.; Maloney, D.J.; Nadler, J.L.; Rai, G.; Simeonov, A.; Taylor-Fishwick, D.A. Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. Mol. Cell. Endocrinol. 2012, 358, 88–95.
51. Brandes, R.P.; Weissmann, N.; Schröder, K. Nox family NADPH oxidases in mechano-transduction: Mechanisms and consequences. Antioxid. Redox Signal. 2014, 20, 887–898.
52. Gyurko, R.; Siqueira, C.C.; Caldon, N.; Gao, L.; Kantarci, A.; Van Dyke, T.E. Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J. Immunol. 2006, 177, 7250–7256.
53. Ushio-Fukai, M. Vascular signaling through G protein-coupled receptors: New concepts. Curr. Opin. Nephrol. Hypertens. 2009, 18, 153–159.
54. Brown, D.I.; Griendling, K.K. Nox proteins in signal transduction. Free Radic. Biol. Med. 2009, 47, 1239–1253.
55. Manea, S.-A.; Constantin, A.; Manda, G.; Sasson, S.; Manea, A. Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms. Redox. Biol. 2015, 5, 358–366.
56. Pendyala, S.; Natarajan, V. Redox regulation of Nox proteins. Respir. Physiol. Neurobiol. 2010, 174, 265–271.
57. Cahill, P.A.; Redmond, E.M. Vascular endothelium—Gatekeeper of vessel health. Atherosclerosis 2016, 248, 97–109.
58. Guzik, T.J. Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease. Arterioscler. Thromb. Vasc. Biol. 2005, 26, 333–339.
59. Gray, S.P.; Di Marco, E.; Okabe, J.; Szyndralewiez, C.; Heitz, F.; Montezano, A.C.; de Haan, J.B.; Koulis, C.; El-Osta, A.; Andrews, K.L.; et al. NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 2013, 127, 1888–1902.
60. Brandes, R.P.; Takac, I.; Schröder, K. No superoxide—No stress?: Nox4, the good NADPH oxidase! Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1255–1257.
61. Ray, R.; Murdoch, C.E.; Wang, M.; Santos, C.X.; Zhang, M.; Alom-Ruiz, S.; Anilkumar, N.; Ouattara, A.; Cave, A.C.; Walker, S.J.; et al. Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1368–1376.
62. Dikalova, A.E.; Góngora, M.C.; Harrison, D.G.; Lambeth, J.D.; Dikalov, S.; Griendling, K.K. Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H673–H679.
63. Förstermann, U. Janus-faced role of endothelial NO synthase in vascular disease: Uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol. Chem. 2006, 387, 1521–1533.
64. Cai, H. Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovasc. Res. 2005, 68, 26–36.
65. Winterbourn, C.C.; Hampton, M.B. Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 2008, 45, 549–561.
66. Selemidis, S.; Sobey, C.G.; Wingler, K.; Schmidt, H.H.H.W.; Drummond, G.R. NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition. Pharmacol. Ther. 2008, 120, 254–291.
67. Hu, L.; Zhang, Y.; Lim, P.; Miao, Y.; Tan, C.; Mckenzie, K.; Schyvens, C.; Whitworth, J. Apocynin but Not l-Arginine Prevents and Reverses Dexamethasone-Induced Hypertension in the Rat. Am. J. Hypertens. 2006, 19, 413–418.
68. Clempus, R.E.; Griendling, K.K. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc. Res. 2006, 71, 216–225.
69. Lee, M.Y.; San Martín, A.; Mehta, P.K.; Dikalova, A.E.; Garrido, A.M.; Datla, S.R.; Lyons, E.; Krause, K.-H.; Banfi, B.; Lambeth, J.D.; et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 480–487.
70. Kim, J.-S.; Huang, T.Y.; Bokoch, G.M. Reactive oxygen species regulate a slingshot-cofilin activation pathway. Mol. Biol. Cell 2009, 20, 2650–2660.
71. Jagadeesha, D.K.; Takapoo, M.; Banfi, B.; Bhalla, R.C.; Miller, F.J. Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration. Cardiovasc. Res. 2012, 93, 406–413.
72. Vendrov, A.E.; Madamanchi, N.R.; Niu, X.-L.; Molnar, K.C.; Runge, M.; Szyndralewiez, C.; Page, P.; Runge, M.S. NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J. Biol. Chem. 2010, 285, 26545–26557.
73. Wang, Z.; Castresana, M.R.; Newman, W.H. Reactive oxygen species-sensitive p38 MAPK controls thrombin-induced migration of vascular smooth muscle cells. J. Mol. Cell. Cardiol. 2004, 36, 49–56.
74. Datla, S.R.; McGrail, D.J.; Vukelic, S.; Huff, L.P.; Lyle, A.N.; Pounkova, L.; Lee, M.; Seidel-Rogol, B.; Khalil, M.K.; Hilenski, L.L.; et al. Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization. Am. J. Physiol. Heart Circ. Physiol. 2014, 307, H945–57.
75. Nguyen, A.T.; Gomez, D.; Bell, R.D.; Campbell, J.H.; Clowes, A.W.; Gabbiani, G.; Giachelli, C.M.; Parmacek, M.S.; Raines, E.W.; Rusch, N.J.; et al. Smooth muscle cell plasticity: Fact or fiction? Circ. Res. 2013, 112, 17–22.
76. Szocs, K. Upregulation of Nox-Based NAD(P)H Oxidases in Restenosis After Carotid Injury. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 21–27.
77. Kazama, K.; Okada, M.; Yamawaki, H. A novel adipocytokine, omentin, inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell migration through antioxidative mechanism. Am. J. Physiol. Heart Circ. Physiol. 2014, 306, H1714–9.
78. Jay, D.B.; Papaharalambus, C.A.; Seidel-Rogol, B.; Dikalova, A.E.; Lassègue, B.; Griendling, K.K. Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic. Biol. Med. 2008, 45, 329–335.
79. Yang, W.; Liu, Z.; Xu, Q.; Peng, H.; Chen, L.; Huang, X.; Yang, T.; Yu, Z.; Cheng, G.; Zhang, G.; et al. Involvement of vascular peroxidase 1 in angiotensin II-induced hypertrophy of H9c2 cells. J. Am. Soc. Hypertens. 2017, 11, 519–529.e1.
80. Manea, A.; Manea, S.-A.; Todirita, A.; Albulescu, I.C.; Raicu, M.; Sasson, S.; Simionescu, M. High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARa and PPARß/d. Cell Tissue Res. 2015, 361, 593–604.
81. Gole, H.K.A.; Tharp, D.L.; Bowles, D.K. Upregulation of intermediate-conductance Ca2+-activated K+ channels (KCNN4) in porcine coronary smooth muscle requires NADPH oxidase 5 (NOX5). PLoS ONE 2014, 9, e105337.
82. Rodríguez, A.I.; Csányi, G.; Ranayhossaini, D.J.; Feck, D.M.; Blose, K.J.; Assatourian, L.; Vorp, D.A.; Pagano, P.J. MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 430–438.
83. Chen, F.; Haigh, S.; Barman, S.; Fulton, D.J.R. From form to function: The role of Nox4 in the cardiovascular system. Front. Physiol. 2012, 3, 412.
84. Coen, M.; Gabbiani, G.; Bochaton-Piallat, M.-L. Myofibroblast-mediated adventitial remodeling: An underestimated player in arterial pathology. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2391–2396.
85. Majesky, M.W. Adventitia and perivascular cells. Arterioscler. Thromb. Vasc. Biol. 2015, 35, e31–e35.
86. Csányi, G.; Taylor, W.R.; Pagano, P.J. NOX and inflammation in the vascular adventitia. Free Radic. Biol. Med. 2009, 47, 1254–1266.
87. Meijles, D.N.; Pagano, P.J. Nox and Inflammation in the Vascular Adventitia. Hypertension 2016, 67, 14–19.
88. Pagano, P.J.; Clark, J.K.; Cifuentes-Pagano, M.E.; Clark, S.M.; Callis, G.M.; Quinn, M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc. Natl. Acad. Sci. USA 1997, 94, 14483–14488.
89. Tieu, B.C.; Lee, C.; Sun, H.; Lejeune, W.; Recinos, A.; Ju, X.; Spratt, H.; Guo, D.-C.; Milewicz, D.; Tilton, R.G.; et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J. Clin. Investig. 2009, 119, 3637–3651.
90. Cifuentes, M.E.; Rey, F.E.; Carretero, O.A.; Pagano, P.J. Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H2234–H2240.
91. Al Ghouleh, I.; Frazziano, G.; Rodriguez, A.I.; Csányi, G.; Maniar, S.; St Croix, C.M.; Kelley, E.E.; Egaña, L.A.; Song, G.J.; Bisello, A.; et al. Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. Cardiovasc. Res. 2013, 97, 134–142.
92. Hinz, B.; Gabbiani, G. Cell-matrix and cell-cell contacts of myofibroblasts: Role in connective tissue remodeling. Thromb. Haemost. 2003, 90, 993–1002.
93. Lassègue, B.; Clempus, R.E. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285, R277–R297.
94. Barnes, J.L.; Gorin, Y. Myofibroblast differentiation during fibrosis: Role of NAD(P)H oxidases. Kidney Int. 2011, 79, 944–956.
95. Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8, 726–736.
96. Valle-Prieto, A.; Conget, P.A. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev. 2010, 19, 1885–1893.
97. Giordano, A.; Galderisi, U.; Marino, I.R. From the laboratory bench to the patient’s bedside: An update on clinical trials with mesenchymal stem cells. J. Cell. Physiol. 2007, 211, 27–35.
98. Nesti, C.; Pasquali, L.; Vaglini, F.; Siciliano, G.; Murri, L. The role of mitochondria in stem cell biology. Biosci. Rep. 2007, 27, 165–171.
99. Chen, C.-T.; Shih, Y.-R.V.; Kuo, T.K.; Lee, O.K.; Wei, Y.-H. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008, 26, 960–968.
100. Suda, T.; Takubo, K.; Semenza, G.L. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011, 9, 298–310.
101. Imhoff, B.R.; Hansen, J.M. Differential redox potential profiles during adipogenesis and osteogenesis. Cell. Mol. Biol. Lett. 2011, 16, 149–161.
102. Turrens, J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. (Lond.) 2003, 552, 335–344.
103. Park, S.G.; Kim, J.H.; Xia, Y.; Sung, J.-H. Generation of reactive oxygen species in adipose-derived stem cells: Friend or foe? Expert Opin. Ther. Targets 2011, 15, 1297–1306.
104. Sart, S.; Song, L.; Li, Y. Controlling Redox Status for Stem Cell Survival, Expansion, and Differentiation. Oxid. Med. Cell. Longev. 2015, 2015, 105-135.
105. Tormos, K.V.; Anso, E.; Hamanaka, R.B.; Eisenbart, J.; Joseph, J.; Kalyanaraman, B.; Chandel, N.S. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab. 2011, 14, 537–544.
106. Carrière, A.; Ebrahimian, T.G.; Dehez, S.; Augé, N.; Joffre, C.; André, M.; Arnal, S.; Duriez, M.; Barreau, C.; Arnaud, E.; et al. Preconditioning by mitochondrial reactive oxygen species improves the proangiogenic potential of adipose-derived cells-based therapy. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 1093–1099.
107. Zhou, D.; Shao, L.; Spitz, D.R. Reactive oxygen species in normal and tumor stem cells. Adv. Cancer Res. 2014, 122, 1–67.
108. Lemasters, J.J.; Holmuhamedov, E. Voltage-dependent anion channel (VDAC) as mitochondrial governator—Thinking outside the box. Biochim. Biophys. Acta 2006, 1762, 181–190.
109. Atashi, F.; Modarressi, A.; Pepper, M.S. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: A review. Stem Cells Dev. 2015, 24, 1150–1163.
110. Vlasits, J.; Jakopitsch, C.; Bernroitner, M.; Zamocky, M.; Furtmüller, P.G.; Obinger, C. Mechanisms of catalase activity of heme peroxidases. Arch. Biochem. Biophys. 2010, 500, 74–81.
111. Wang, L.; Duan, Q.; Wang, T.; Ahmed, M.; Zhang, N.; Li, Y.; Li, L.; Yao, X. Mitochondrial Respiratory Chain Inhibitors Involved in ROS Production Induced by Acute High Concentrations of Iodide and the Effects of SOD as a Protective Factor. Oxid. Med. Cell. Longev. 2015, 2015, 217-670.
112. Huang, H.; Kim, H.J.; Chang, E.-J.; Lee, Z.H.; Hwang, S.J.; Kim, H.-M.; Lee, Y.; Kim, H.-H. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: Implications for bone remodeling. Cell Death Differ. 2009, 16, 1332–1343.
113. Kim, J.H.; Song, S.-Y.; Park, S.G.; Song, S.U.; Xia, Y.; Sung, J.-H. Primary involvement of NADPH oxidase 4 in hypoxia-induced generation of reactive oxygen species in adipose-derived stem cells. Stem Cells Dev. 2012, 21, 2212–2221.
114. Rodrigues, M.; Turner, O.; Stolz, D.; Griffith, L.G.; Wells, A. Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand. Cell Transplant. 2012, 21, 2171–2187.
115. Dickinson, B.C.; Peltier, J.; Stone, D.; Schaffer, D.V.; Chang, C.J. Nox2 redox signaling maintains essential cell populations in the brain. Nat. Chem. Biol. 2011, 7, 106–112.
116. Kang, X.; Wei, X.; Jiang, L.; Niu, C.; Zhang, J.; Chen, S.; Meng, D. Nox2 and Nox4 regulate self-renewal of murine induced-pluripotent stem cells. IUBMB Life 2016, 68, 963–970.
117. Kanda, Y.; Hinata, T.; Kang, S.W.; Watanabe, Y. Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells. Life Sci. 2011, 89, 250–258.
118. Kim, J.H.; Park, S.-H.; Park, S.G.; Choi, J.-S.; Xia, Y.; Sung, J.-H. The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells. Stem Cells Dev. 2011, 20, 1753–1761.
119. Schröder, K.; Wandzioch, K.; Helmcke, I.; Brandes, R.P. Nox4 acts as a switch between differentiation and proliferation in preadipocytes. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 239–245.
120. Kennedy, E.; Mooney, C.J.; Hakimjavadi, R.; Fitzpatrick, E.; Guha, S.; Collins, L.E.; Loscher, C.E.; Morrow, D.; Redmond, E.M.; Cahill, P.A. Adult vascular smooth muscle cells in culture express neural stem cell markers typical of resident multipotent vascular stem cells. Cell Tissue Res. 2014, 358, 203–216.
121. Kennedy, E.; Hakimjavadi, R.; Greene, C.; Mooney, C.J.; Fitzpatrick, E.; Collins, L.E.; Loscher, C.E.; Guha, S.; Morrow, D.; Redmond, E.M.; et al. Embryonic rat vascular smooth muscle cells revisited—A model for neonatal, neointimal SMC or differentiated vascular stem cells? Vasc. Cell 2014, 6, 6.
122. Dan, P.; Velot, É.; Decot, V.; Menu, P. The role of mechanical stimuli in the vascular differentiation of mesenchymal stem cells. J. Cell Sci. 2015, 128, 2415–2422.
123. Khani, M.-M.; Tafazzoli-Shadpour, M.; Goli-Malekabadi, Z.; Haghighipour, N. Mechanical characterization of human mesenchymal stem cells subjected to cyclic uniaxial strain and TGF-ß1. J. Mech. Behav. Biomed. Mater. 2015, 43, 18–25.
124. Heo, J.S.; Lee, J.-C. ß-Catenin mediates cyclic strain-stimulated cardiomyogenesis in mouse embryonic stem cells through ROS-dependent and integrin-mediated PI3K/Akt pathways. J. Cell. Biochem. 2011, 112, 1880–1889.
125. Li, R.; Chen, B.; Wang, G.; Yu, B.; Ren, G.; Ni, G. Effects of mechanical strain on oxygen free radical system in bone marrow mesenchymal stem cells from children. Injury 2011, 42, 753–757.
126. Goettsch, C.; Goettsch, W.; Arsov, A.; Hofbauer, L.C.; Bornstein, S.R.; Morawietz, H. Long-term cyclic strain downregulates endothelial Nox4. Antioxid. Redox Signal. 2009, 11, 2385–2397.
127. Xiao, Q.; Luo, Z.; Pepe, A.E.; Margariti, A.; Zeng, L.; Xu, Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am. J. Physiol. Cell Physiol. 2009, 296, C711–C723.
128. Baek, S.; Lee, K.P.; Jung, S.H.; Cui, L.; Ko, K.; Kim, B.; Won, K.J. DJ-1 Regulates Differentiation of Human Mesenchymal Stem Cells into Smooth Muscle-like Cells in Response to Sphingosylphosphorylcholine. Proteomics 2017, doi:10.1002/pmic.201700208.
129. Mahadev, K.; Motoshima, H.; Wu, X.; Ruddy, J.M.; Arnold, R.S.; Cheng, G.; Lambeth, J.D.; Goldstein, B.J. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 2004, 24, 1844–1854.
130. Pepe, A.E.; Xiao, Q.; Zampetaki, A.; Zhang, Z.; Kobayashi, A.; Hu, Y.; Xu, Q. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ. Res. 2010, 106, 870–879.
131. Xiao, Q.; Pepe, A.E.; Wang, G.; Luo, Z.; Zhang, L.; Zeng, L.; Zhang, Z.; Hu, Y.; Ye, S.; Xu, Q. Nrf3-Pla2g7 interaction plays an essential role in smooth muscle differentiation from stem cells. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 730–744.
132. Coant, N.; Ben Mkaddem, S.; Pedruzzi, E.; Guichard, C.; Tréton, X.; Ducroc, R.; Freund, J.-N.; Cazals-Hatem, D.; Bouhnik, Y.; Woerther, P.-L.; et al. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol. Cell. Biol. 2010, 30, 2636–2650.
133. Urao, N.; Inomata, H.; Razvi, M.; Kim, H.W.; Wary, K.; McKinney, R.; Fukai, T.; Ushio-Fukai, M. Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ. Res. 2008, 103, 212–220.
134. Kramann, R.; Goettsch, C.; Wongboonsin, J.; Iwata, H.; Schneider, R.K.; Kuppe, C.; Kaesler, N.; Chang-Panesso, M.; Machado, F.G.; Gratwohl, S.; et al. Adventitial MSC-like Cells Are Progenitors of Vascular Smooth Muscle Cells and Drive Vascular Calcification in Chronic Kidney Disease. Cell Stem Cell 2016, 19, 628–642.
135. Nemenoff, R.A.; Horita, H.; Ostriker, A.C.; Furgeson, S.B.; Simpson, P.A.; VanPutten, V.; Crossno, J.; Offermanns, S.; Weiser-Evans, M.C.M. SDF-1a induction in mature smooth muscle cells by inactivation of PTEN is a critical mediator of exacerbated injury-induced neointima formation. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1300–1308.
136. Herring, B.P.; Hoggatt, A.M.; Burlak, C.; Offermanns, S. Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury. Vasc. Cell 2014, 6, 21.
137. Chappell, J.; Harman, J.L.; Narasimhan, V.M.; Yu, H.; Foote, K.; Simons, B.D.; Bennett, M.R.; Jorgensen, H.F. Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models. Circ. Res. 2016, 119, 1313–1323.
138. Lee, M.; San Martín, A.; Valdivia, A.; Martin-Garrido, A.; Griendling, K.K. Redox-Sensitive Regulation of Myocardin-Related Transcription Factor (MRTF-A) Phosphorylation via Palladin in Vascular Smooth Muscle Cell Differentiation Marker Gene Expression. PLoS ONE 2016, 11, e0153199.
139. Yu, S.-S.; Chen, B.; Huang, C.-K.; Zhou, J.-J.; Huang, X.; Wang, A.-J.; Li, B.-M.; He, W.-H.; Zhu, X. Ursolic acid suppresses TGF-ß1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling. Exp. Ther. Med. 2017, 14, 3577–3582.
140. Redmond, E.M.; Hamm, K.; Cullen, J.P.; Hatch, E.; Cahill, P.A.; Morrow, D. Inhibition of patched-1 prevents injury-induced neointimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 1960–1964.
141. Jimenez, S.A.; Piera-Velazquez, S. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality? Matrix Biol. 2016, 51, 26–36.
142. Kang, X.; Wei, X.; Wang, X.; Jiang, L.; Niu, C.; Zhang, J.; Chen, S.; Meng, D. Nox2 contributes to the arterial endothelial specification of mouse induced pluripotent stem cells by upregulating Notch signaling. Sci. Rep. 2016, 6, doi:10.1038/srep33737.
143. Shao, J.-S.; Aly, Z.A.; Lai, C.-F.; Cheng, S.-L.; Cai, J.; Huang, E.; Behrmann, A.; Towler, D.A. Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann. N. Y. Acd. Sci. 2007, 1117, 40–50.